no image available Dickens & Co. "Cutting the Odds: How Adjuvant GM-CSF Therapy Revolutionizes Melanoma Treatment" "Unveiling the Game-Changing Impact of GM-CSF on Survival Rates in High-Risk Stage IIIC Melanoma Patients" Price: 25.00€